Omeros (OMER) Finished Goods (2014 - 2021)

Omeros' (OMER) quarterly Finished Goods came in at $184000.0 in Q3 2021, down 72.37% year-on-year from $666000.0 in Q3 2020, and down 52.45% quarter-over-quarter from $387000.0 in Q2 2021.

Omeros (OMER) Finished Goods (2014 - 2021) Analysis & Trends

Omeros has disclosed Finished Goods across 8 years of filings, most recently posting $184000.0 for Q3 2021.

  • Finished Goods for Q3 2021 came in at $184000.0, down 72.37% year-over-year; the trailing twelve-month figure through Sep 2021 was $184000.0 (down 72.37% YoY), and the FY2020 annual result was $784000.0, up 9.19% from the prior year.
  • Finished Goods came in at $184000.0 for Q3 2021 at Omeros, down from $387000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $784000.0 in Q4 2020 to a low of $5000.0 in Q4 2018.
  • The 5-year median for Finished Goods is $586000.0 (2019), against an average of $509076.9.
  • Across the five-year window, Finished Goods tumbled 98.61% in 2018 and soared 14260.0% in 2019, its largest moves.
  • Omeros' Finished Goods stood at $360000.0 in 2017, then sank by 98.61% to $5000.0 in 2018, then jumped by 14260.0% to $718000.0 in 2019, then increased by 9.19% to $784000.0 in 2020, then tumbled by 76.53% to $184000.0 in 2021.
  • The last three Finished Goods figures came in at $184000.0 (Q3 2021), $387000.0 (Q2 2021), and $544000.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 184,000.00
Jun 30, 2021 387,000.00
Mar 31, 2021 544,000.00
Dec 31, 2020 784,000.00
Sep 30, 2020 666,000.00
Jun 30, 2020 606,000.00
Mar 31, 2020 726,000.00
Dec 31, 2019 718,000.00
Sep 30, 2019 751,000.00
Jun 30, 2019 586,000.00
Mar 31, 2019 301,000.00
Dec 31, 2018 5,000.00
Dec 31, 2017 360,000.00
Dec 31, 2016 173,000.00
Dec 31, 2015 221,000.00
Dec 31, 2014 568,000.00